News
03-11-2015, 02:14 AM
Researchers at Sanford-Burnham Medical Research Institute have discovered a mechanism that explains why some breast cancer tumors respond to specific chemotherapies and others do not. The findings highlight the level of glutamine, an essential nutrient for cancer development, as a determinant of breast cancer response to select anticancer therapies, and identify a marker associated with glutamine uptake, for potential prognosis and stratification of breast cancer therapy.
More... (http://www.news-medical.net/news/20150311/Sanford-Burnham-researchers-discover-control-mechanism-for-glutamine-uptake-in-breast-cancer-cells.aspx)
More... (http://www.news-medical.net/news/20150311/Sanford-Burnham-researchers-discover-control-mechanism-for-glutamine-uptake-in-breast-cancer-cells.aspx)